BLLN vs CDNA: stock comparison and AI forecast
Billiontoone, Inc. (BLLN) and Caredx, Inc. (CDNA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BLLN Billiontoone, Inc.
- Market Cap
- $5.30B
- P/E Ratio
- 312.2x
- Size
- mid-cap
- AI Forecast
CDNA Caredx, Inc.
- Price
- $76.33 +256.0% · 6M
- Market Cap
- $4.01B
- P/E Ratio
- 38.4x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BLLN is 1.3 times larger than CDNA by market capitalization ($5.30B against $4.01B).
- CDNA trades at 38.4 times trailing earnings, BLLN at 312.2 times.
- CDNA turns 25.9% of its revenue into net income, against 6.8% for BLLN.
- Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BLLN | CDNA |
|---|---|---|
| Market Cap | $5.30B | $4.01B |
| P/E Ratio | 312.17x | 38.36x |
| P/B Ratio | – | 8.58x |
| EPS | $0.36 | $1.99 |
| Book Value/Share | – | $8.90 |
| Revenue/Share | $11.92 | $9.47 |
| FCF/Share | $0.72 | – |
Profitability & Margins
| Metric | BLLN | CDNA |
|---|---|---|
| ROE | – | 27.5% |
| ROA | – | 20.1% |
| ROIC | – | 22.9% |
| Gross Margin | 70.0% | – |
| Operating Margin | 12.2% | 23.2% |
| Net Margin | 6.8% | 25.9% |
| EBT Margin | 13.7% | 25.0% |
| Tax Rate | 1.0% | -3.5% |
Financial Health
| Metric | BLLN | CDNA |
|---|---|---|
| Current Ratio | 11.25x | 2.31x |
| Quick Ratio | 10.89x | 2.25x |
| D/E Ratio | – | 0.37x |
| Financial Leverage | – | 1.37x |
| Interest Coverage | 6.7x | – |
| Working Capital | $621M | $182M |
Cash Flow
| Metric | BLLN | CDNA |
|---|---|---|
| Operating Cash Flow | $48M | $69M |
| Free Cash Flow | $34M | – |
| Capital Spending | -$14M | – |
| OCF Growth YoY | – | 62.2% |
| FCF/Sales | 6.0% | – |
| CapEx/Sales | 2.5% | – |
Operational Efficiency
| Metric | BLLN | CDNA |
|---|---|---|
| Asset Turnover | – | 0.78x |
| Receivables Turnover | 6.4x | 10.4x |
| Inventory Turnover | 7.7x | – |
| Fixed Assets Turnover | 21.0x | 18.4x |
| Days Sales Outstanding | 57 days | 35 days |
| Days Inventory | 47 days | – |
| Payables Period | 22 days | – |
| Cash Conversion Cycle | 82 days | – |
Income Statement
| Metric | BLLN | CDNA |
|---|---|---|
| Total Revenue | $562M | $497M |
| Operating Income | $41M | $115M |
| Net Income | $23M | $129M |
| R&D Expense | $89M | $84M |
| SG&A Expense | $264M | $344M |
| Cost of Goods Sold | $169M | – |
Dividend & Shareholder Information
| Metric | BLLN | CDNA |
|---|---|---|
| Shares Outstanding | 47M | 53M |
| Net Income Growth | – | 111.7% |
| EPS Growth | – | 80.9% |
BLLN vs CDNA: stock comparison and AI forecast
Which is bigger, BLLN or CDNA?
BLLN is 1.3 times larger than CDNA by market capitalization ($5.30B against $4.01B).
Which is cheaper on earnings, BLLN or CDNA?
CDNA trades at 38.4 times trailing earnings, BLLN at 312.2 times.
Which one does Intratio's AI model rank higher, BLLN or CDNA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.